![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
May 1, 2024
A new trial in sarcoma; MSI testing for gastroesophageal cancer; Spring Group Meeting and ASCO highlights
May 1, 2024
Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
April 9, 2024
A new trial in glioblastoma; leadership transitions; upcoming Group Meeting highlights
April 9, 2024
Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
March 7, 2024
Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
December 19, 2023
The co-chairs reflect on the year's key accomplishments and look ahead to 2024
December 19, 2023
The Fall 2023 Group Meeting was notable for a prominent increase in attention to diversity, equity, and inclusion
December 19, 2023
In an annual evaluation, 46 member networks and programs met rigorous standards established by ECOG-ACRIN to indicate exemplary cancer research
December 16, 2023
Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
August 25, 2023
Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
June 30, 2023
Reflections on the spring conference season, including highlights from the recent Group Meeting; updates on the ComboMATCH precision medicine initiative
June 30, 2023
At a recent meeting, ECOG-ACRIN leaders and members celebrated the conclusion of enrollment to the landmark NCI-MATCH clinical trial